ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 146 filers reported holding ALLAKOS INC in Q4 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,417 | -47.9% | 27,056 | 0.0% | 0.00% | – |
| Q2 2023 | $117,964 | +51.2% | 27,056 | +98.5% | 0.00% | – |
| Q1 2022 | $78,000 | -41.4% | 13,630 | 0.0% | 0.00% | – |
| Q4 2021 | $133,000 | -90.8% | 13,630 | +0.4% | 0.00% | -100.0% |
| Q3 2021 | $1,438,000 | +24.1% | 13,579 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $1,159,000 | -12.4% | 13,579 | +17.8% | 0.00% | -33.3% |
| Q1 2021 | $1,323,000 | -13.6% | 11,527 | +5.3% | 0.00% | 0.0% |
| Q4 2020 | $1,532,000 | +124.0% | 10,944 | +30.3% | 0.00% | +50.0% |
| Q3 2020 | $684,000 | +13.4% | 8,398 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $603,000 | +37.7% | 8,398 | -14.7% | 0.00% | 0.0% |
| Q1 2020 | $438,000 | -52.6% | 9,844 | +1.6% | 0.00% | -50.0% |
| Q4 2019 | $924,000 | +55.3% | 9,693 | +28.0% | 0.00% | +100.0% |
| Q3 2019 | $595,000 | +107.3% | 7,570 | +14.4% | 0.00% | 0.0% |
| Q2 2019 | $287,000 | +27.0% | 6,618 | +18.9% | 0.00% | 0.0% |
| Q1 2019 | $226,000 | – | 5,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |